The paradigm shift in ANCA-associated vasculitis: prime time for the complement targeting

Rheumatology (Oxford). 2023 Aug 1;62(8):2633-2634. doi: 10.1093/rheumatology/kead188.

Authors

Luca Quartuccio¹, Elena Treppo¹, Federico Alberici²

Affiliations

¹ Division of Rheumatology, Department of Medicine, University of Udine, Udine, Italy.
² Nephrology Unit, University of Brescia, Azienda Socio Sanitaria Territoriale Spedali Civili, Brescia, Italy.

PMID: 37084252
DOI: 10.1093/rheumatology/kead188

No abstract available

Publication types

Comment

MeSH terms

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
Antibodies, Antineutrophil Cytoplasmic
Complement System Proteins
Humans

Substances

Complement System Proteins
Antibodies, Antineutrophil Cytoplasmic